Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-26

Clinical Trial Update: Study of FORTEO Use in Subjects in the Community Setting

View source ↗

Summary

A completed study evaluating the use of FORTEO (teriparatide) in community-settings for osteoporosis, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2012-06-26